icon
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
icon Mon 26 Oct 2026
Beta version
icon
Official Saudi government website domains end with gov.sa

All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.

icon
Official Reliable websites use HTTPS

Ensure the website is using the HTTPS protocol.

icon

Registered with the Digital Government Authority under number:

20250831619
Suggestions

الأخبار العلمية

SFDA Grants Orphan Drug Designation to “Sephience”
icon 2026-01-28

SFDA Grants Orphan Drug Designation to “Sephience”

The Saudi Food and Drug Authority (SFDA) has granted PTC Therapeutics orphan drug designation to Sephience (sepiapterin), which is indicated for the...
More
1
icon 2026-07-22

SFDA Grants Orphan Drug Designation to Gritgen Therapeutics for PKU Treatment

The Saudi Food and Drug Authority (SFDA) has granted orphan drug designation to Gritgen Therapeutics Co., Ltd. for its “GS1168 Injection” intended for...
More
4
icon 2026-05-24

SFDA GrantsBreakthroughDesignation toPrevent and ReduceBleedingEpisodes in Patients with HemophiliaA

The Saudi Food and Drug Authority (SFDA) has granted Novo Nordisk Breakthrough designation to (FREHEMGO), which is indicated as a long-term routine...
More
1
icon 2026-07-21

SFDA Suspends Registration of Drug Tavneos (avacopan)

The Saudi Food and Drug Authority (SFDA) has announced the suspension of the registration for the drug (Avacopan), commercially known as Tavneos. This...
More
The SFDA Approves Breakthrough Designation Application for Breast Cancer Therapy “Inluriyo”
icon 2025-05-05

The SFDA Approves Breakthrough Designation Application for Breast Cancer Therapy “Inluriyo”

The Saudi Food and Drug Authority (SFDA) has granted Breakthrough Designation to Eli Lilly’s medication, Imlunestrant (Inluriyo), for the treatment of...
More
حموضة البروبيونيك الوراثي
icon 2025-05-04

The SFDA Approves Clinical Trial for Novel Biologic Therapy for Genetic Propionic Acidemia

Experimental Treatment by mRNA The Saudi Food and Drug Authority (SFDA) has approved a clinical study registration titled "A Global Phase 1/2 Open...
More